Cargando…
Plasma desmosine for prediction of outcomes after acute myocardial infarction
BACKGROUND: Elastin degradation is implicated in the pathology of vulnerable plaque. Recent studies show promising results for plasma desmosine (pDES), an elastin-specific degradation product, as a marker of cardiovascular disease (CVD) outcomes. The aim of this study was to investigate the potentia...
Autores principales: | Ali, Kashan, Israr, Muhammad Zubair, Ng, Leong L., Mordi, Ify, Lang, Chim C., Kuzmanova, Elena, Huang, Jeffrey T-J, Choy, Anna-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719937/ https://www.ncbi.nlm.nih.gov/pubmed/36479574 http://dx.doi.org/10.3389/fcvm.2022.992388 |
Ejemplares similares
-
Plasma Desmosine and Abdominal Aortic Aneurysm Disease
por: Mordi, Ify R., et al.
Publicado: (2019) -
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021) -
Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
por: Mordi, Natalie A, et al.
Publicado: (2017) -
Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023) -
COVID-19-Associated Cardiovascular Complications
por: Lee, Clement C. E., et al.
Publicado: (2021)